Safety Data SheetChemical Risk Assessment

Arimidex Tablets

by AstraZeneca

SDS · PDF, approx. 220 KB CRA · PDF, approx. 180 KB

Arimidex Tablets is supplied by AstraZeneca under product code 13224. This page provides both the Safety Data Sheet (SDS) and the Chemical Risk Assessment (CRA) for this substance, under NOHSC regulations for UK workplace use under COSHH. The full SDS and CRA documents are available to download above.

This SDS was last revised on 16 August 2018. The matching CRA is updated in line with SDS revisions. Workplaces handling this substance should retain a current SDS and risk assessment for the duration of use.


Language
English
Regulation
NOHSC
Revision Date
16 Aug 2018
Signal Word
DANGER
Product Code
13224
CAS Number
,120511-73-1

Switch between the Safety Data Sheet and the Chemical Risk Assessment for this substance.

Hazards at a GlanceFrom the Safety Data Sheet
Signal Word: DANGER

Health hazardGHS08Health hazard
EnvironmentGHS09Environment
Hazard Statements (H-phrases)
H351
Suspected of causing cancer.
H360
May damage fertility or the unborn child.
H373
May cause damage to organs through prolonged or repeated exposure.
H411
Toxic to aquatic life with long lasting effects.

Need the full hazard breakdown? Precautionary statements, first aid, physical properties and exposure controls are in the full SDS PDF.


Common QuestionsAbout this Safety Data Sheet

Need help with Safety Data Sheets? You've come to the right place!

CONTACT US